Brain Cancer Trial, Recruiting NCT06140875 Sponsor: Charite University, Berlin, Germany Condition: Brain Cancer
Back to Brain Cancer

Brain Cancer Trial, Recruiting

NCT06140875
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been recently diagnosed with glioblastoma (a type of brain tumour), confirmed by a tissue sample and classified according to standard medical guidelines
  • You are between 18 and 70 years old and are generally able to carry out most daily activities with minimal limitations
  • You are willing and able to sign a consent form agreeing to take part
  • Your blood counts, kidney function, and liver function are within acceptable levels (confirm with trial site for exact values)
  • You have already had surgery to remove most or all of the tumour
  • If your tumour has a specific genetic marker called MGMT-promoter methylation, you must have chosen not to follow a particular chemotherapy regimen that includes a drug called Lomustine
  • You are planned to receive a standard combination of radiotherapy (60 Gy over six weeks) together with a chemotherapy drug called temozolomide, followed by six further cycles of temozolomide

Who may not be able to join:

  • You have previously had radiation treatment to the head or brain
  • You have received chemotherapy, anti-cancer drugs, or radiation therapy for any cancer in the last 5 years
  • You have a history of other cancers or serious health conditions that are expected to significantly shorten your life expectancy
  • After your brain surgery, there are signs of dangerous pressure building up inside your skull (confirm with trial site)
  • You are unable to have MRI or CT scans, or you have a known allergy to the contrast dye used in these scans
  • You have a pacemaker, defibrillator, deep brain stimulator, or certain metal implants that would make a specific type of treatment device unsafe to use
  • You are of childbearing age and are unwilling or unable to use effective contraception during the trial
  • You are currently pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +49 30 450 527318

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
15 November 2023
Est. completion
14 May 2029

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

PFS at 6 months

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov